CME / CE

Substance Use in Adults and Adolescents: Screening, Brief Intervention and Referral to Treatment (SBIRT)

Authors: Mitra Ahadpour, MD; Reed Forman, MSW; Erich Kleinschmidt, MSW
CME / CE Released: 9/16/2014; Reviewed and Renewed: 4/21/2017
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 4/21/2018

Target Audience and Goal Statement

This activity is intended for primary care physicians, pediatricians, psychiatrists, emergency physicians, dentists, chiropractors, social workers, nurses, nurse practitioners, and physician assistants.

The goal of this activity is to address the basic principles of SBIRT as well as coding and reimbursement for the implementation of SBIRT in practice.

Upon completion of this activity, participants will be able to:

Define "screening, brief intervention, and referral to treatment (SBIRT)"
Propose screening strategies for problematic substance use using evidence-based tools
Propose appropriate strategies to engage patients to discuss their substance use
Identify strategies for brief interventions or referrals to treatment

Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Authors

Mitra Ahadpour, MD

Medical Officer, Substance Abuse and Mental Health Services Administration, Rockville, Maryland

Disclosures

Disclosure: Mitra Ahadpour, MD, has disclosed no relevant financial relationships.

Dr Ahadpour does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr Ahadpour does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Reed Forman, MSW

Lead Public Health Advisor, Substance Abuse and Mental Health Services Administration, Rockville, Maryland

Disclosures

Disclosure: Walker R. Forman, MSW, has disclosed no relevant financial relationships.

Mr Forman does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Mr Forman does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Erich Kleinschmidt, MSW

Health Services Officer, Substance Abuse and Mental Health Services Administration, Rockville, Maryland

Disclosures

Disclosure: Erich Kleinschmidt, MSW, has disclosed no relevant financial relationships.

Mr Kleinschmidt does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Mr Kleinschmidt does not intend to discuss investigational drugs, mechanical devices, biologics, or diagnostics not approved by the FDA for use in the United States.

Additional Reviewers

Editor

Jane Lowers

Director of government strategy, Medscape, LLC

Disclosures

Disclosure: Jane Lowers has disclosed no relevant financial relationships.

Writer

Lynne Kolton Schneider, PhD

Freelance writer, Boca Raton, Florida

Disclosures

Disclosure: Lynne Kolton Schneider, PhD, has disclosed no relevant financial relationships.

Additional Planners/Reviewers

Kellie Cosby, MPH

Public Health Advisor, SAMHSA

Disclosures

Disclosure: Kellie Cosby, MPH, has disclosed no relevant financial relationships.

Holly Hagle, PhD

Director, National SBIRT Addiction Technology Transfer Center, Substance Abuse and Mental Health Services Administration

Disclosures

Disclosure: Holly Hagle, PhD, has disclosed no relevant financial relationships.

Suzan Swanton, MSW

Public Health Advisor, Substance Abuse and Mental Health Services Administration

Disclosures

Disclosure: Suzan Swanton, MSW, has disclosed no relevant financial relationships.

Sharon Levy, MD, MPH

Assistant Professor of Pediatrics, Harvard University

Disclosures

Disclosure: Sharon Levy, MD, MPH, has disclosed no relevant financial relationships.

Lydia Schrier, MD, MPH

Director of Clinic-Based Research, Division of Adolescent/Young Adult Medicine, Boston Children’s Hospital

Disclosures

Disclosure: Lydia Schrier, MD, MPH, has disclosed no relevant financial relationships.

CME Reviewer

Nafeez Zawahir, MD

CME Clinical Director, Medscape, LLC

Disclosures

Disclosure: Nafeez Zawahir, MD, has disclosed no relevant financial relationships.

Nurse Planner

Amy Bernard, MS, BSN, RN-BC

Lead Nurse Planner, Medscape, LLC

Disclosures

Disclosure: Amy Bernard, MS, BSN, RN-BC, has disclosed no relevant financial relationships.

Accreditation Statements

For Physicians

Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Medscape, LLC staff have disclosed that they have no relevant financial relationships.

Contact This Provider

For Nurses

Medscape, LLC is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Awarded 1.75 contact hour(s) of continuing nursing education for RNs and APNs; none of these is in the area of pharmacology.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Public Health & Prevention

CME / CE

Substance Use in Adults and Adolescents: Screening, Brief Intervention and Referral to Treatment (SBIRT)

Authors: Mitra Ahadpour, MD; Reed Forman, MSW; Erich Kleinschmidt, MSWFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / CE Released: 9/16/2014; Reviewed and Renewed: 4/21/2017

Valid for credit through: 4/21/2018

processing....

Page 1 of 18

Introduction and Overview

CME / CE Information

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient is intended or should be inferred.

The material presented here does not necessarily reflect the views of Medscape, LLC, or companies that support educational programming on medscape.org. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Faculty and Disclosures

Authors

Mitra Ahadpour, MD

Reed Forman, MSW

Erich Kleinschmidt, MSW

Editor

Jane Lowers

Writer

Lynne Kolton Schneider, PhD

Additional Planners/Reviewers

Kellie Cosby, MPH

Holly Hagle, PhD

Suzan Swanton, MSW

Sharon Levy, MD, MPH

Lydia Schrier, MD, MPH

CME Reviewer

Nafeez Zawahir, MD

Nurse Planner

Amy Bernard, MS, BSN, RN-BC

CME / CE

Substance Use in Adults and Adolescents: Screening, Brief Intervention and Referral to Treatment (SBIRT)

Target Audience and Goal Statement

Disclosures

Authors

Mitra Ahadpour, MD

Reed Forman, MSW

Erich Kleinschmidt, MSW

Editor

Jane Lowers

Writer

Lynne Kolton Schneider, PhD

Additional Planners/Reviewers

Kellie Cosby, MPH

Holly Hagle, PhD

Suzan Swanton, MSW

Sharon Levy, MD, MPH

Lydia Schrier, MD, MPH

CME Reviewer

Nafeez Zawahir, MD

Nurse Planner

Amy Bernard, MS, BSN, RN-BC

Accreditation Statements

For Physicians

For Nurses

Instructions for Participation and Credit

Substance Use in Adults and Adolescents: Screening, Brief Intervention and Referral to Treatment (SBIRT)